Market closedNon-fractional

Inovio Pharmaceuticals/INO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Inovio Pharmaceuticals

Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Ticker

INO

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Plymouth Meeting, United States

Employees

122

INO Metrics

BasicAdvanced
$231M
Market cap
-
P/E ratio
-$5.53
EPS
1.16
Beta
-
Dividend rate
$231M
1.16
4.773
4.622
11.935
14.217
-112.28%
-38.56%
-85.09%
281.606
2.2
2.2
-1.733
-92.95%
-52.66%
-51.93%
-24.70%

What the Analysts think about INO

Analyst Ratings

Majority rating from 6 analysts.
Buy

INO Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
-100.00%
Net income
-$30M
21.60%
Profit margin
0.00%
-100.00%

INO Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 30.56%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$1.56
-$1.56
-$1.12
-$1.31
-
Expected
-$1.74
-$1.52
-$1.27
-$1.00
-$1.10
Surprise
-10.34%
2.63%
-11.64%
30.56%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Inovio Pharmaceuticals stock?

Inovio Pharmaceuticals (INO) has a market cap of $231M as of July 06, 2024.

What is the P/E ratio for Inovio Pharmaceuticals stock?

The price to earnings (P/E) ratio for Inovio Pharmaceuticals (INO) stock is 0 as of July 06, 2024.

Does Inovio Pharmaceuticals stock pay dividends?

No, Inovio Pharmaceuticals (INO) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Inovio Pharmaceuticals dividend payment date?

Inovio Pharmaceuticals (INO) stock does not pay dividends to its shareholders.

What is the beta indicator for Inovio Pharmaceuticals?

Inovio Pharmaceuticals (INO) has a beta rating of 1.16. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Inovio Pharmaceuticals stock

Buy or sell Inovio Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing